# Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes

> **NCT07383155** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Shenyang Northern Hospital** · enrollment: 5270 (estimated)

## Conditions studied

- Percutaneous Coronary Intervention
- High Bleeding Risk
- Acute Coronary Syndromes
- Anticoagulant Therapy

## Interventions

- **DRUG:** Anticoagulant Therapy

## Key facts

- **NCT ID:** NCT07383155
- **Lead sponsor:** Shenyang Northern Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 5270 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07383155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07383155, "Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07383155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*